CIPLA LIMITED

INDIA

No. 815, Sansad Marg, Hanuman Road Area, Connaught Place, New Delhi, Delhi 110001, India

New Delhi, India

Maps

233

Total Medicines

181

Active

Dosage Forms

Countries

Kenya (65) Tanzania (63) Zambia (36) Rwanda (20) Ghana (17) Zimbabwe (14) Uganda (13) Botswana (5)

Location

No. 815, Sansad Marg, Hanuman Road Area, Connaught Place, New Delhi, Delhi 110001, India

Open in OpenStreetMap approx.

Registration Status

Registered 181

3 months to expiry 11

Unknown 9

PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) 9

Valid 6

Withdrawn 6

PRESCRIPTION PREPARATIONS 10TH SCHEDULE, (P.P.10) 4

Suspended 4

Retained 2

PHARMACIST INITIATED MEDICINES, (P.I.M.) 1

Dosage Forms

Tablets 25 TABLET, COATED; ORAL 12 Capsules 11 Tablet Uncoated 9 Film Coated Tablet 8 TABLETS 7 Syrup 6 Film-Coated Tablet 6

Therapeutic Classes

GENERIC/BIOSIMILARS 47

NEW/INNOVATOR 6

Local Agents / Applicants

Cipla Ltd 75

CIPLA LIMITED 68

Cipla Limited 21

CIPLA LTD 17

Worldwide Healthcare... 11

CIPLA MEDPRO Parc du Cap... 5

Distributing Wholesalers

Licensed wholesalers / distributors that carry this MAH's brands.

Eastleigh Pharmaceutical

Eastleigh, Nairobi

12 SKUs

Generics Africa

Nairobi

3 SKUs

Browse all wholesalers

Other Products

Medical Devices (1)

zerostat vT

Registered Medicines

Showing 20 of 233 · Page 5 of 12

Search all

Product	Form / Strength	Country	Reg. Number	Status
ERLOCIP 100 ERLOTINIB HYDROCHLORIDE	100	Kenya	H2021/CTD7413/14567	Registered
ERLOCIP 150 Erlotinib Hydrochloride 150 mg	Tablets 150	Tanzania	TZ 19 H 0071	Registered/Compliant
ERLOCIP 150 ERLOTINIB HYDROCHLORIDE	150 MG	Kenya	H2021/CTD7405/14549	Registered
ERLOCIP 25 Erlotinib Hydrochloride, 25 mg	Film coated tablets 25 mg	Rwanda	Rwanda FDA-HMP-MA-1656	Registered
ERLOCIP 25 ERLOTINIB	TABLET, COATED; ORAL 25MG	Zimbabwe	2021/9.4/6187	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
ERLOCIP 25 ERLOTINIB HYDROCHLORIDE	25	Kenya	H2021/CTD7414/14568	Registered
ERLOCIP 25 Erlotinib Hydrochloride 25 mg	Tablets 25	Tanzania	TZ 19 H 0069	Registered/Compliant
ESOMAC 20 MUPS Esomeprazole Magnesium Dihydrate 20 mg	Tablets	Tanzania	TZ 19 H 0139	Registered/Compliant
ESOMAC 20 MUPS ESOMEPRAZOLE MAGNESIUM DIHYDRATE TABLETS 20 MG	EACH FILM COATED TABLETS CONTAINS: ESOMEPRAZOLE MAGNESIUM DIHYDRATE PH.EUR EQUIVALENT TO ESOMEPRAZOLE ............................. 20 MG (AS ENTERIC COATED PELLETS) COLOUR: IRON OXIDE RED AND TITANIUM DIOXIDE EXCIPIENT WITH KNOWN EFFECT: SUCROSE	Kenya	H2022/CTD7538/14678	Registered
ESOMAC 40 MUPS Esomeprazole Magnesium Dihydrate 40 mg	Tablets	Tanzania	TZ 19 H 0140	Registered/Compliant
ESOMAC 40 MUPS Esomeprazole Magnesium Dehydrate 40mg	Film Coated Tablets 40 mg	Rwanda	Rwanda FDA-HMP-MA-1350	Registered
ESOMAC 40 MUPS ESOMEPRAZOLE MAGNESIUM DIHYDRATE	TABLET, COATED; ORAL 40 MG	Zimbabwe	2022/16.7/6274	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
ESOMAC 40 MUPS ESOMEPRAZOLE MAGNESIUM DIHYDRATE	EACH FILM COATED TABLETS CONTAINS: ESOMEPRAZOLE MAGNESIUM DIHYDRATE PH.EUR EQUIVALENT TO ESOMEPRAZOLE ............................. 40 MG (AS ENTERIC COATED PELLETS) COLOUR: IRON OXIDE RED, IRON OXIDE BLACK, TITANIUM DIOXIDE AND ERYTHROSINE	Kenya	H2022/CTD7559/14721	Registered
ESOMEPRAZOLE MAGNESIUM DIHYDRATE -	ORAL SOLID ORDINARY FILM-COATED TABLETS 40 MG	Uganda	NDA/MAL/HDP/9611	Registered
ESOMEPRAZOLE MAGNESIUM DIHYDRATE -	ORAL SOLID ORDINARY FILM-COATED TABLETS 20 MG	Uganda	NDA/MAL/HDP/9612	Registered
EXTENDED RELEASE TABLETS (Each tablet contains Empagliflozin/Metformin Hydrochloride 10mg/1000mg) Empagliflozin/Metformin Hydrochloride	Empagliflozin/Metformin Hydrochloride 10mg/1000mg	Ghana	FDA/GD.233-060073	3 months to expiry
EXTENDED RELEASE TABLETS (Each tablet contains Empagliflozin/Metformin Hydrochloride 12.5mg/1000mg) Empagliflozin/Metformin Hydrochloride	Empagliflozin/Metformin Hydrochloride 10mg/1000mg	Ghana	FDA/GD.233-060072	3 months to expiry
EXTENDED RELEASE TABLETS (Each tablet contains Empagliflozin/Metformin Hydrochloride 25mg/1000mg) Empagliflozin/Metformin Hydrochloride	Empagliflozin/Metformin Hydrochloride 25mg/1000mg	Ghana	FDA/GD.233-060074	3 months to expiry
EXTENDED RELEASE TABLETS (Each tablet contains Empagliflozin/Metformin Hydrochloride 5mg/1000mg) Empagliflozin/Metformin Hydrochloride	Empagliflozin/Metformin Hydrochloride 5mg/1000mg	Ghana	FDA/GD.233-060071	3 months to expiry
Efavirenz; Lamivudine; Tenofovir Disoproxil Fumarate tablet 400 mg; 300 mg; 300mg Efavirenz 400mg mg,Lamivudine 300mg mg	Film-coated Tablets 300mg mg,400mg mg	Zambia	ZAMRA-HM-25-49	Registered/Compliant

Prev 1 ... 3 4 5 6 7 ... 12 Next

233 products